MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration

News   Mar 27, 2015

 
MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration
 
 
 

RELATED ARTICLES

UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPO

News

MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).

READ MORE

Study in Mouse Model of Autism Finds Mother's Microbiome Determines Risk

News

The microbiome is the collection of microorganisms, such as bacteria, that naturally live inside us. New research in a mouse model suggests the microbiome determines autism risk.

READ MORE

DNA ‘Shield’ Discovered with Crucial Roles in Normal Cell Division, the Immune System & Cancer

News

Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy